CD4 and COVID-19: In particular, COVID-19 moderate patients and recovered individuals from severe disease, when compared to HD, reported higher percentages of IFN-γ+IL-2+TNF+, IFN-γ+TNF+ and IL-2+TNF+ within CD4+ T cells.